Vaccine-induced antibodies can limit Salmonella infection in the absence of complement or macrophages.

Saved in:
Bibliographic Details
Title: Vaccine-induced antibodies can limit Salmonella infection in the absence of complement or macrophages.
Authors: Perez-Toledo M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Aksu-Istil K; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Marcial-Juarez E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Persaud RR; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Alshayea A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia., Jossi SE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Carestia A; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Canada., von Meijenfeld F; University Medical Center Groningen, Groningen, the Netherlands., Botto M; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom., James LC; MRC Laboratory of Molecular Biology, Cambridge, United Kingdom., Surewaard B; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Canada., Afzal Z; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Shields AM; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Horsnell WG; Division of Immunology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom., Lopez-Macias C; Medical Research Unit in Immunochemistry, Specialty Hospital, National Medical Center Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico., Henderson IR; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Jenne CN; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Canada., Cunningham AF; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Corporate Authors: OptiVaNTS consortium
Source: MBio [mBio] 2026 Apr 08; Vol. 17 (4), pp. e0284625. Date of Electronic Publication: 2026 Feb 25.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2150-7511 (Electronic) NLM ISO Abbreviation: mBio Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2150-7511
DOI:10.1128/mbio.02846-25